Humana Inc. (hum)

HUM — Company Overview

Investors tracking HUM follow a Healthcare Plans name listed on NYQ within Healthcare.

HUM — Business Description

The business profile of Humana Inc. (HUM) reflects its role in Healthcare Plans. Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterW…

Official website: https://www.humana.com.

HUM — Investment Thesis

Humana Inc. (HUM) attracts investors weighing Healthcare Plans fundamentals against current market pricing.

• Revenue is expanding at roughly 26.2% year-over-year (public data).
• Trailing P/E of 36.11× implies elevated growth expectations at the current price.
• Forward P/E (22.62×) is below trailing P/E — earnings may be expected to improve.
• Dividend yield near 0.9% adds an income component to total return.
• Equity market capitalization is approximately $45.00B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

HUM — Financial Health

HUM financial profile reflects operating efficiency and capital structure using available market fundamentals.

Profit margin near 0.9% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $1.94B supports balance-sheet flexibility.

HUM — Growth Outlook

Growth outlook for Humana Inc. (HUM) depends on demand trends in Healthcare Plans and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 26.2% indicates strong top-line momentum.
• Earnings growth of 27.1% year-over-year supports improving profitability.
• Price is 12.6% below the 52-week high.

HUM — Competitive Position

Humana Inc. (HUM) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Healthcare Plans.
• Market capitalization of $45.00B places HUM among large-cap peers.
• Gross margin of 13.7% should be benchmarked against direct competitors.

HUM — Summary

Humana Inc. (HUM) is a large-cap Healthcare company focused on Healthcare Plans, listed on NYQ. Last price $374.78 with market cap $45.00B. Trailing P/E 36.11×. Revenue grew 26.2% year-over-year per public data. Notable strengths include revenue growth of 26.2% year-over-year. Key watch items include elevated trailing p/e (36.11×) limits valuation margin of safety. Review free estimates and earnings pages for HUM; upgrade for institutional ownership and live headlines.